Cargando…
P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429302/ http://dx.doi.org/10.1097/01.HS9.0000968656.94193.a5 |
_version_ | 1785090677824028672 |
---|---|
author | Wijnen, Noa Barneh, Farnaz Meulendijks, Thomas Klein, Kim Duddebach, Ester Cornel, Annelisa Dautzenberg, Noël Ashtiani, Minoo Krippner-Heidenreich, Anja Nierkens, Stefan Heidenreich, Olaf Kaspers, Gertjan |
author_facet | Wijnen, Noa Barneh, Farnaz Meulendijks, Thomas Klein, Kim Duddebach, Ester Cornel, Annelisa Dautzenberg, Noël Ashtiani, Minoo Krippner-Heidenreich, Anja Nierkens, Stefan Heidenreich, Olaf Kaspers, Gertjan |
author_sort | Wijnen, Noa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104293022023-08-17 P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES Wijnen, Noa Barneh, Farnaz Meulendijks, Thomas Klein, Kim Duddebach, Ester Cornel, Annelisa Dautzenberg, Noël Ashtiani, Minoo Krippner-Heidenreich, Anja Nierkens, Stefan Heidenreich, Olaf Kaspers, Gertjan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429302/ http://dx.doi.org/10.1097/01.HS9.0000968656.94193.a5 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Wijnen, Noa Barneh, Farnaz Meulendijks, Thomas Klein, Kim Duddebach, Ester Cornel, Annelisa Dautzenberg, Noël Ashtiani, Minoo Krippner-Heidenreich, Anja Nierkens, Stefan Heidenreich, Olaf Kaspers, Gertjan P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES |
title | P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES |
title_full | P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES |
title_fullStr | P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES |
title_full_unstemmed | P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES |
title_short | P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES |
title_sort | p437: effective immunotherapy of pediatric t(8;21) acute myeloid leukemia by repurposing cd3xcd19 targeting bispecific antibodies |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429302/ http://dx.doi.org/10.1097/01.HS9.0000968656.94193.a5 |
work_keys_str_mv | AT wijnennoa p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT barnehfarnaz p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT meulendijksthomas p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT kleinkim p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT duddebachester p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT cornelannelisa p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT dautzenbergnoel p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT ashtianiminoo p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT krippnerheidenreichanja p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT nierkensstefan p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT heidenreicholaf p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies AT kaspersgertjan p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies |